Regadenoson .08 mg/mL (Regadenoson INJECTION, SOLUTION) .08 mg/mL

Regadenoson .08 mg/mL is a pharmaceutical solution used for specific medical imaging procedures. This intravenous injection is designed to enhance diagnostic accuracy in certain cardiovascular assessments.

Strength

.08 mg/mL

Pack Size

1 SYRINGE, PLASTIC in 1 CARTON (0641-6253-01) / 5 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Regadenoson .08 mg/mL is primarily used as a pharmacological stress agent in myocardial perfusion imaging (MPI). This injection helps to simulate the effects of physical exercise on the heart, aiding in the evaluation of coronary artery disease. Patients who are unable to undergo physical stress testing may benefit from this solution, as it provides an alternative method for assessing blood flow to the heart muscle.

Side Effects

Common effects of Regadenoson .08 mg/mL may include temporary increases in heart rate and blood pressure, as well as flushing or warmth. Some individuals might experience shortness of breath, dizziness, or headache. These effects are generally short-lived and subside quickly after administration.

Precautions & Warnings

Regadenoson .08 mg/mL should be handled with care, ensuring proper storage and administration by healthcare professionals. It is essential to follow all safety guidelines and protocols when using this injection. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Regadenoson .08 mg/mL may interact with other medications, particularly those affecting heart rate or blood pressure. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain substances may also influence the effects of this injection.

Frequently Asked Questions

Regadenoson .08 mg/mL is used as a pharmacological stress agent in myocardial perfusion imaging to evaluate coronary artery disease.

Regadenoson .08 mg/mL is administered intravenously by healthcare professionals in a clinical setting.

Common effects may include temporary increases in heart rate and blood pressure, flushing, shortness of breath, dizziness, or headache.

Patients with certain medical conditions or allergies should consult their healthcare provider before using Regadenoson .08 mg/mL.

Yes, Regadenoson .08 mg/mL may interact with medications affecting heart rate or blood pressure, so it's important to inform healthcare providers about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.